Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 18 Issue 1, January 2022

Off the beaten peptide path

Shown is the tropical greenhouse of the Matthaei Botanical Gardens. Plants from botanical collections at the University of Michigan have been used for the bioinformatic discovery of plant peptides with new side-chain macrocyclizations derived from a copper-dependent autocatalytic peptide cyclase called the BURP domain.

See Chigumba et al.

Image credit: Eric Bronson, University of Michigan, Ann Arbor. Cover Design: Alex Wing

Research Highlights

Top of page ⤴

News & Views

  • An autocatalytic peptide cyclase defines a new subclass of plant ribosomally synthesized and post-translationally modified peptides (RiPPs). This discovery explains the origins of a large family of cyclic peptides and inspires new tools for mining these RiPPs across the plant kingdom.

    • Yit-Heng Chooi
    News & Views
  • Genetic code expansion is emerging as a promising strategy to precisely regulate protein expression. A new study engineered cells that enabled noncanonical-amino-acid-triggered insulin expression to rapidly regulate blood glucose levels in a diabetic mouse model.

    • Jicheng Yu
    • Yuqi Zhang
    • Zhen Gu
    News & Views
  • The molecular mechanism through which chromatin-bound RNA-binding proteins (chrRBPs) control transcription remains obscure. A new study reveals that chrRBPs can compartmentalize RNA and transcription machinery into a phase-separated condensate, thus modulating gene expression.

    • Chengyu Li
    • Huasong Lu
    News & Views
  • A new study demonstrates that the receptor-binding domain of the SARS-CoV-2 spike protein binds to sialylated glycans, especially glycolipids, to facilitate viral entry, an insight that identifies new potential targets for SARS-CoV-2 interventions.

    • Ryuta Uraki
    • Yoshihiro Kawaoka
    News & Views
Top of page ⤴

Perspectives

Top of page ⤴

Articles

Top of page ⤴

Amendments & Corrections

Top of page ⤴

Search

Quick links